Industry Focus

Healthcare: Celgene's Deal – Happy Management Does It Again

Informações:

Sinopsis

Motley Fool's Michael Douglass and Todd Campbell shed light on how Celgene's deal-making frenzy positions it as a potential MS leader and offer up insight into how to value immuno-oncology stocks.